Tokyo Tape
Sign in
← Medinet

Quarterly report · Q1

2370.TEDINET S100Q5ZZ
Period2022-10-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
MetricValuePeriodScopeSource row
Revenue¥185m2022-10-01 → 2022-12-31StandaloneNet sales
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales (5-year summary)
Revenue¥173m2021-10-01 → 2021-12-31StandaloneNet sales
Operating income−¥325m2022-10-01 → 2022-12-31StandaloneOperating income
Operating income−¥340m2021-10-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥324m2022-10-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥341m2021-10-01 → 2021-12-31StandaloneOrdinary income
Profit before tax−¥324m2022-10-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥341m2021-10-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥326m2022-10-01 → 2022-12-31StandaloneProfit loss
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneNet income loss (5-year summary)
Net income−¥342m2021-10-01 → 2021-12-31StandaloneProfit loss
Total assets¥5.5bnat 2022-12-31StandaloneAssets
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥5.5bnat 2021-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥448mat 2022-12-31StandaloneLiabilities
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Net assets / equity¥5.0bnat 2022-12-31StandaloneNet assets
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥5.0bnat 2021-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥4.1bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
EPS (basic)¥-1.542022-10-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.882021-10-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio91.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued211,730,423at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued184,950,423at 2021-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥161m
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2022-10-01 → 2022-12-31¥158,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2022-10-01 → 2022-12-31¥158,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2022-10-01 → 2022-12-31−¥107m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2022-10-01 → 2022-12-31¥185m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2022-10-01 → 2022-12-31¥185m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2022-10-01 → 2022-12-31−¥57m
—segment totalrevenue2022-10-01 → 2022-12-31¥185m
—segment totalrevenue external2022-10-01 → 2022-12-31¥185m
—segment totalsegment profit2022-10-01 → 2022-12-31−¥164m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2021-12-31−¥135m
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2021-12-31¥47,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2021-12-31¥47,000
jpcrp040300-q1r_E05351-000Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2021-12-31−¥157m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2021-12-31¥173m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2021-12-31¥173m
jpcrp040300-q1r_E05351-000Contract Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2021-12-31−¥47m
—segment totalrevenue2021-10-01 → 2021-12-31¥173m
—segment totalrevenue external2021-10-01 → 2021-12-31¥173m
—segment totalsegment profit2021-10-01 → 2021-12-31−¥205m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 299
ItemContextValueUnit
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember184994000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember158000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember185153000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember185153000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember-57415000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q1r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember-107019000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember-164435000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-161063000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-325498000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-02-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第28期第１四半期（自　2022年10月１日　至　2022年12月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社メディネット
Company name in english cover pageFilingDateInstantMEDINET Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　久布白　兼直
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都品川区勝島一丁目５番21号（同所は登記上の本店所在地であり、実際の業務は「最寄りの連絡場所」で行っております。）
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)該当事項はありません。
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都大田区平和島六丁目１番１号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)（０３）６６３１－１２０１（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役経営管理部長　落合　雅三
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE05351
Fund codeFilingDateInstant－
Security codeFilingDateInstant23700
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社メディネット
Filer name in englishFilingDateInstantMEDINET Co., Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Current fiscal year start dateFilingDateInstant2022-10-01
Current period end dateFilingDateInstant2022-12-31
Type of current periodFilingDateInstantQ1
Current fiscal year end dateFilingDateInstant2023-09-30
Previous fiscal year start dateFilingDateInstant2021-10-01
Comparative period end dateFilingDateInstant2021-12-31
Previous fiscal year end dateFilingDateInstant2022-09-30

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-09-30pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-10-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass